SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001580642-23-000874
Filing Date
2023-02-14
Accepted
2023-02-14 15:00:46
Documents
1
Group Members
FINNY KURUVILLA, M.D. PH. D.ROBIN C. JOHN

Document Format Files

Seq Description Document Type Size
1 SC 13G/A sutrobio13ga.htm SC 13G/A 55816
  Complete submission text file 0001580642-23-000874.txt   57591
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Subject) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90656 | Film No.: 23627645
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE INTERNATIONAL PLACE SUITE 4210 BOSTON MA 02110
Business Address ONE INTERNATIONAL PLACE SUITE 4210 BOSTON MA 02110 877-771-3836
EVENTIDE ASSET MANAGEMENT, LLC (Filed by) CIK: 0001442891 (see all company filings)

IRS No.: 262508416 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A